Five-year analysis of protective isolation.
D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D003365:Costs and Cost Analysis; D003428:Cross Infection / Q000517:prevention & control; D003587:Cytomegalovirus / Q000276:immunology; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D007958:Leukocyte Count; D007970:Leukopenia / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D010357:Patient Isolators; D011552:Pseudomonas Infections / Q000517:prevention & control; D012075:Remission, Spontaneous; D012698:Serologic Tests; D018139:Simplexvirus / Q000302:isolation & purification; D013203:Staphylococcal Infections / Q000517:prevention & control
D000906:Antibodies